Dental device maker Align Technology's Q2 revenue slightly beats estimates
ALGN•Key quarterly figures
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Slight Beat* | $1.06 bln | $1.05 bln (13 Analysts) |
| Q2 Adjusted EPS | Beat | $2.64 | $2.61 (15 Analysts) |
| Q2 EPS | $1.51 | ||
| Q2 Adjusted Net Income | Beat | $189.1 mln | $185.28 mln (12 Analysts) |
| Q2 Net Income | $108.3 mln | ||
| Q2 Adjusted Operating Margin | 22.9% | ||
| Q2 Gross Profit | $757.43 mln |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Q2 revenue and earnings slightly beat estimates
- US dental device maker's Q2 revenue rose 4.3% yr/yr, slightly beating analyst expectations
- Adjusted EPS for Q2 beat analyst expectations
- Company repurchased $67 mln in shares during the quarter
Outlook remains for sequentially lower Q3 revenue
- Align expects Q3 revenue between $1.0 bln and $1.02 bln, down sequentially
- Company maintains 2026 revenue growth guidance of up 3% to 4% year-over-year
- Align expects Q3 gross margin to fall due to $20-$30 mln in one-time charges
